饮食诱导减重在伴与不伴2型糖尿病的肥胖个体中对脂蛋白(a)水平的影响
该临床研究在四个独立队列中检测了能量限制饮食3-4个月前后血浆脂蛋白(a)[Lp(a)]水平。主要队列131例以肥胖为主的2型糖尿病患者减重9.9%后Lp(a)升高14.8 nmol/l(95% CI 10.2, 20.6),两个不伴2型糖尿病的肥胖队列减重后Lp(a)中位数亦升高,而减重手术队列Lp(a)无显著变化。结论认为饮食诱导减重伴随Lp(a)升高,可能拮抗其心脏代谢获益。
要点
- 主要队列2型糖尿病患者能量限制饮食减重9.9%(95% CI 8.9, 10.8)后Lp(a)升高14.8 nmol/l(95% CI 10.2, 20.6)。
- 队列2和队列3减重8.5%(95% CI 6.5, 10.6)和6.5%(95% CI 5.7, 7.2)后Lp(a)中位数分别升高13.5 nmol/l(95% CI 2.3, 30.0)和11.9 nmol/l(95% CI 5.7, 19.0)(均p < 0.05)。
- 队列4减重手术减重14.0%(95% CI 12.2, 15.7)后Lp(a)无显著变化(-7.0 nmol/l;95% CI -18.8, 5.3)。
核心结论
- 饮食诱导减重在伴与不伴2型糖尿病的肥胖个体中伴随Lp(a)水平升高,而常规心血管疾病危险因素改善。
- Lp(a)水平升高可能潜在拮抗饮食诱导减重带来的有益心脏代谢效应。
研究设计与样本
- 临床研究,在四个独立研究队列中于能量限制饮食3-4个月前后测定血浆Lp(a)水平,采用免疫比浊法。
- 主要队列(队列1)为131例以肥胖为主的2型糖尿病患者,均为POWER试验参与者。
- 次要队列包括队列2(30例伴2型糖尿病的肥胖患者)、队列3(37例不伴2型糖尿病的肥胖个体)和队列4(26例接受减重手术的不伴2型糖尿病的肥胖个体)。
主要发现
- 主要队列能量限制饮食致体重下降9.9%(95% CI 8.9, 10.8),LDL-胆固醇等常规心血管疾病危险因素改善,Lp(a)升高14.8 nmol/l(95% CI 10.2, 20.6)。
- 主要队列单因素分析中,Lp(a)变化与基线Lp(a)水平相关(r = 0.38,p < 0.001),与LDL-胆固醇变化相关(r = 0.19,p = 0.033)。
- 队列2和队列3体重分别下降8.5%(95% CI 6.5, 10.6)和6.5%(95% CI 5.7, 7.2),Lp(a)中位数分别升高13.5 nmol/l(95% CI 2.3, 30.0)和11.9 nmol/l(95% CI 5.7, 19.0)(均p < 0.05)。
- 合并队列1-3后,饮食诱导的Lp(a)升高与体重下降相关(r = 0.178,p = 0.012)。
- 队列4减重14.0%(95% CI 12.2, 15.7),Lp(a)无显著变化(-7.0 nmol/l;95% CI -18.8, 5.3)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Elevated levels of lipoprotein(a) [Lp(a)] are an independent risk factor for cardiovascular disease (CVD), particularly in individuals with type 2 diabetes. Although weight loss improves conventional risk factors for CVD in type 2 diabetes, the effects on Lp(a) are unknown and may influence the long-term outcome of CVD after diet-induced weight loss. The aim of this clinical study was to determine the effect of diet-induced weight loss on Lp(a) levels in obese individuals with type 2 diabetes. METHODS: Plasma Lp(a) levels were determined by immunoturbidimetry in plasma obtained before and after 3-4 months of an energy-restricted diet in four independent study cohorts. The primary cohort consisted of 131 predominantly obese patients with type 2 diabetes (cohort 1), all participants of the Prevention Of Weight Regain in diabetes type 2 (POWER) trial. The secondary cohorts consisted of 30 obese patients with type 2 diabetes (cohort 2), 37 obese individuals without type 2 diabetes (cohort 3) and 26 obese individuals without type 2 diabetes who underwent bariatric surgery (cohort 4). RESULTS: In the primary cohort, the energy-restricted diet resulted in a weight loss of 9.9% (95% CI 8.9, 10.8) and improved conventional CVD risk factors such as LDL-cholesterol levels. Lp(a) levels increased by 14.8 nmol/l (95% CI 10.2, 20.6). In univariate analysis, the change in Lp(a) correlated with baseline Lp(a) levels (r = 0.38, p < 0.001) and change in LDL-cholesterol (r = 0.19, p = 0.033). In cohorts 2 and 3, the weight loss of 8.5% (95% CI 6.5, 10.6) and 6.5% (95% CI 5.7, 7.2) was accompanied by a median increase in Lp(a) of 13.5 nmol/l (95% CI 2.3, 30.0) and 11.9 nmol/l (95% CI 5.7, 19.0), respectively (all p < 0.05). When cohorts 1-3 were combined, the diet-induced increase in Lp(a) correlated with weight loss (r = 0.178, p = 0.012). In cohort 4, no significant change in Lp(a) was found (-7.0 nmol/l; 95% CI -18.8, 5.3) despite considerable weight loss (14.0%; 95% CI 12.2, 15.7). CONCLUSIONS/INTERPRETATION: Diet-induced weight loss was accompanied by an increase in Lp(a) levels in obese individuals with and without type 2 diabetes while conventional CVD risk factors for CVD improved. This increase in Lp(a) levels may potentially antagonise the beneficial cardiometabolic effects of diet-induced weight reduction.
引用
- Berk KA, Yahya R, Verhoeven AJM, et al. Effect of diet-induced weight loss on lipoprotein(a) levels in obese individuals with and without type 2 diabetes. Diabetologia. 2017. PMID: 28386638. doi:10.1007/s00125-017-4246-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。